Literature DB >> 10490480

Dual chamber implantable cardioverter defibrillator benefits and limitations.

K Fan1, K Lee, C P Lau.   

Abstract

UNLABELLED: Dual chamber ICD capable of providing dual chamber pacing (DDD) and ventricular arrhythmia therapy is now available. We report our experience of clinical performance of dual chamber ICDs amongst Chinese population.
METHODS: 9 patients (6 men and 3 women) received dual chamber ICDs, mean age 50 +/- 18.8 years. The indications were ventricular fibrillation (VF) [5], hemodynamic intolerant ventricular tachycardia (VT) [3] and unexplained syncope plus positive induction of VF [1]. The underlying cardiac pathology were congenital LQT syndrome(1), hypertrophic cardiomyopathy [2], coronary artery disease [2], rheumatic valvular disease [1], Brugada syndrome [1], arrhythmogenic right ventricular dysplasia [1] and idiopathic VF [1]. Four patients have documented paroxysmal atrial fibrillation (AF). All patients have defibrillation thresholds (DFT) determined with a binary search protocol starting at 12 joules (J) at implantation.
RESULTS: A total of 34 episodes of VF were induced at implantation with mean DFT 13.8 +/- 7 J. The average shocking impedance was 40 +/- 3.6 Omega. The mean acute P wave measured 3.3 +/- 1.3 mV and R wave measured 13.2 +/- 3.2 mV. Atrial and ventricular thresholds, at pulse width 0.5 ms, averaged 0.8 +/- 0.4 V and 0.4 +/- 0.2 V. During follow-up period, 16 episodes of VF were documented and were successfully treated with the first programmed shock. In the patient with LQT syndrome, DDD was initiated to prevent pause-dependant VF. Three episodes of inappropriate therapy (15.8%) were delivered. One patient experienced 2 shocks after exercise. Stored electrograms showed sinus tachycardia with first degree heart block which was misdiagnosed as VT with retrograde 1:1 conduction. Another inappropriate therapy occurred with AF with fast ventricular response within the VF zone and VT therapy inhibitor was disabled.
CONCLUSION: Dual chamber ICD allows combined benefits of DDD and VT/VF therapy. Storage of both atrial and ventricular electrograms provide more information in elucidation of nature of dysarrhythmias. Inappropriate shocks, though reduced, are still possible and the rigid algorithms of SVT discrimination from VT will need further published.

Entities:  

Mesh:

Year:  1999        PMID: 10490480     DOI: 10.1023/a:1009847707872

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  22 in total

1.  Limitations and late complications of third-generation automatic cardioverter-defibrillators.

Authors:  S O Nunain; M Roelke; T Trouton; S Osswald; Y H Kim; G Sosa-Suarez; D R Brooks; B McGovern; M Guy; D F Torchiana
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

Review 2.  Benefits and lessons learned from stored electrogram information in implantable defibrillators.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; D Schwartzman; M Preminger
Journal:  J Cardiovasc Electrophysiol       Date:  1995-10

3.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

4.  Stability: an ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia.

Authors:  S L Higgins; R S Lee; R L Kramer
Journal:  J Cardiovasc Electrophysiol       Date:  1995-12

5.  The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators.

Authors:  P J Best; D L Hayes; M S Stanton
Journal:  Pacing Clin Electrophysiol       Date:  1999-01       Impact factor: 1.976

6.  Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator.

Authors:  C Wolpert; W Jung; C Scholl; S Spehl; J Cyran; B Lüderitz
Journal:  J Cardiovasc Electrophysiol       Date:  1998-08

7.  Use of atrial and ventricular electrograms from a dual chamber implantable cardioverter defibrillator to elucidate a complex dysrhythmia.

Authors:  R M Greenberg; F T Degeratu
Journal:  Pacing Clin Electrophysiol       Date:  1998-10       Impact factor: 1.976

8.  Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome.

Authors:  M Eldar; J C Griffin; G F Van Hare; C Witherell; A Bhandari; D Benditt; M M Scheinman
Journal:  J Am Coll Cardiol       Date:  1992-10       Impact factor: 24.094

9.  Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.

Authors:  C D Swerdlow; P S Chen; R M Kass; J R Allard; C T Peter
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

10.  Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.

Authors:  W Grimm; B F Flores; F E Marchlinski
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

View more
  3 in total

1.  Characterization of the 16 blanking periods of the Medtronic GEM DR dual chamber defibrillators.

Authors:  S S Barold; F Cantens
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 2.  Implantable dual-chamber cardioverter-defibrillator-pacemaker.

Authors:  D Pfeiffer; M Mende; A Hagendorff
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

Review 3.  Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?

Authors:  K L Lee; C P Lau
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.